Valley Hope of Tulsa
7718 East 91st Street, Suite 120, Tulsa, OK 74133
Valley Hope of Tulsa is an intensive outpatient and outpatient facility in Tulsa, OK offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicaid, and private insurance.
Licenses and accreditations
- State department of healthLicensed by the state's department of health.
- State substance use treatment agencyLicensed by the state's substance use treatment agency.
- The Joint CommissionAccredited by The Joint Commission.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Intensive outpatient treatment
- Several hours of treatment a day, several days a week, while living at home.
- Outpatient
- Regular appointments while living at home.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Accepts clients using MAT but prescribed elsewhere
- Accepts clients whose medication for opioid use is prescribed elsewhere.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Indian Health Service, tribal, or urban Indian health funds; Medicaid; Private health insurance.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Clients with co-occurring mental and substance use disorders; Veterans.
More details this facility reports
- External Opioid Medications Source
- Other contracted prescribing entity.
- Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity; Other contracted prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Disulfiram; Naltrexone (extended-release, injectable); Naltrexone (oral).
- Treatment Approaches
- 12-step facilitation; Anger management; Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling.
- Facility Operation (e.g., Private, Public)
- Private non-profit organization.
- Assessment/Pre-treatment
- Comprehensive substance use assessment; Outreach to persons in the community; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
- Transitional Services
- Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
- Recovery Support Services
- Housing services; Mentoring/peer support; Self-help groups.
- Education and Counseling Services
- Family counseling; Group counseling; HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Marital/couples counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
- Ancillary Services
- Case management service; Suicide prevention services; Transportation assistance.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.